Volume 29, Supplement A, 2007
Selected Proceedings of the 7th Annual European Round Table on Fabry Disease: Towards Comprehensive Disease Management
Christoph Wanner, MD; and Stephen Waldek, MB, BCh, FACP
Guest Editors
Contents
Foreward
Christoph Wanner, MD; and Stephen Waldek, MB, BCh, FRCP
[PDF]
Fabry Disease Model: A Rational Approach to the Management of Fabry Disease
Christoph Wanner, MD
[PDF]
Pediatrics: Implementing the Promise of Early Intervention for Fabry Disease
Annick Raas-Rothschild, MD
[PDF]
Assessing Antibodies to a-Galactosidase A in Fabry Disease
Susan M. Richards, PhD
[PDF]
Stroke and Brain Structural Alterations in Fabry Disease
Andreas Fellgiebel, MD, PhD
[PDF]
Peripheral Nervous System Involvement in Fabry Disease: Role in Morbidity and Mortality
Max J. Hilz, MD, PhD
[PDF]
Progression of Fabry Cardiomyopathy
Jörg Strotmann, MD; Frank Breunig, MD; Christoph Wanner, MD; and Frank Weidemann, MD
[PDF]
Staging of Fabry Disease Using Renal Biopsies
João Paulo Oliveira, MD, MSc
[PDF]
Fabry Disease: The Need to Stratify Patient Populations to Better Understand the Outcome of Enzyme Replacement Therapy
Dominique P. Germain, MD,PhD
[PDF]
Poster Abstracts
[PDF]
Support for this supplement was provided by Genzyme Europe BV, Naarden, The Netherlands.
To view articles available in the current issue, you will need Adobe Acrobat Reader®.
To download, click here:
Copyright © Excerpta Medica, Inc.